Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation

NCT00080236 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation
Hepatitis
Cholestasis
Carcinoma, Hepatocellular

Interventions

DRUG: IDN-6556
DRUG: Placebo

Sponsor

Conatus Pharmaceuticals Inc.

Collaborators

[object Object]